Beyond the liver in patients with non-alcoholic fatty liver disease (NAFLD)-cause for concern?

Matthew J Armstrong^{1

2}, Geoffrey Haydon¹, Wing-Kin Syn^{3

4}

Affiliations

¹ Liver Unit, Queen Elizabeth University Hospital Birmingham, Birmingham, UK.
² Centre for Liver Research, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK.
³ Section of Gastroenterology, Ralph H Johnson Veterans Affairs Medical Center, Charleston, South Carolina, USA.
⁴ Division of Gastroenterology and Hepatology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.

Editorial

Matthew J Armstrong et al. Hepatobiliary Surg Nutr. 2018 Apr.

. 2018 Apr;7(2):138-142.

doi: 10.21037/hbsn.2018.01.09.

Matthew J Armstrong^{1

2}, Geoffrey Haydon¹, Wing-Kin Syn^{3

4}

¹ Liver Unit, Queen Elizabeth University Hospital Birmingham, Birmingham, UK.
² Centre for Liver Research, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK.
³ Section of Gastroenterology, Ralph H Johnson Veterans Affairs Medical Center, Charleston, South Carolina, USA.
⁴ Division of Gastroenterology and Hepatology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.
Adams LA, Anstee QM, Tilg H, Targher G. Adams LA, et al. Gut. 2017 Jun;66(6):1138-1153. doi: 10.1136/gutjnl-2017-313884. Epub 2017 Mar 17. Gut. 2017. PMID: 28314735 Review.

1. Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver Fibrosis, but no Other Histologic Features, Associates with Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology 2015;149:389-97.e10. 10.1053/j.gastro.2015.04.043 - DOI - PMC - PubMed
1. Ekstedt M, Hagström H, Nasr P, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 2015;61:1547-54. 10.1002/hep.27368 - DOI - PubMed
1. Adams LA, Anstee QM, Tilg H, et al. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 2017;66:1138-53. 10.1136/gutjnl-2017-313884 - DOI - PubMed
1. Armstrong MJ, Adams LA, Canbay A, et al. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology 2014;59:1174-97. 10.1002/hep.26717 - DOI - PubMed
1. Oni ET, Agatston AS, Blaha MJ, et al. A systematic review: burden and severity of sub-clinical cardiovascular disease among those with nonalcoholic fatty liver; should we care? Atherosclerosis 2013;230:258-67. 10.1016/j.atherosclerosis.2013.07.052 - DOI - PubMed